LRRK2 and Parkinson disease: Over the past two decades, research recognized that also mutations in the gene encoding leucine-rich repeat kinase 2 (LRRK2) are a common risk factor in both monogenic and sporadic forms of Parkinson’s disease [78], and more and more LRRK2 variants have been detected in different cohorts of PD patients with different geographical or ethnic origins.